Berkeley Research Group Remains at The Towers Emeryville

The life science market in Emeryville is booming, with industry experts reporting that the region is poised to become one of the nation’s leading life science hubs. In fact, more than 150 biotech companies including Novartis, Bayer Healthcare, Amyris and Zymergen are currently located in Emeryville. One factor is its proximity to San Francisco and Silicon Valley, which tracked a vacancy rate of only 5.7 percent in first quarter 2021.

KBS recently signed a 20,256-square-foot lease renewal with Berkeley Research Group at The Towers Emeryville, a 593,484-square-foot office park. The property is owned by KBS Real Estate Investment Trust III.

This transaction, which extends BRG’s occupancy of a full floor at the property, demonstrates tenants’ continued demand for premier office space in top locations within primary U.S. markets, according to Gio Cordoves, Western regional president for KBS.

“KBS has consistently targeted the best properties in key growth markets across the U.S.,” says Cordoves. “As part of the East Bay, The Towers Emeryville increasingly draws in companies seeking easy access to San Francisco and unobstructed panoramic views from virtually every floor of the San Francisco Bay, the San Francisco skyline and the Golden Gate Bridge as well as downtown Oakland.”